GMP Training Under NOM-059 for Pharmaceutical Manufacturing in Mexico

GMP training under NOM-059 for pharmaceutical manufacturing in Mexico: requirements, implementation and full regulatory compliance with COFEPRIS.

LeaderlixNovember 4, 2026GMP training NOM-059 pharmaceutical manufacturing Mexico
GMP Training Under NOM-059 for Pharmaceutical Manufacturing in Mexico

GMP training under NOM-059 for pharmaceutical manufacturing in Mexico is a set of specialized training programs designed to ensure compliance with Mexican Official Standards on good manufacturing practices. It covers the requirements of NOM-059-SSA1-2013 and other applicable Mexican regulations, giving pharmaceutical staff the knowledge they need to maintain the quality, safety and efficacy standards required by COFEPRIS.

Fundamentals of Good Manufacturing Practices in Mexico

Good Manufacturing Practices (GMP) in Mexico are regulated mainly by NOM-059-SSA1-2013, which sets the specifications and procedures for demonstrating that a facility manufacturing medicines operates in line with good manufacturing practices. The standard is fundamental to ensuring that pharmaceutical products are consistently manufactured to appropriate quality standards.

The Mexican regulatory system takes a comprehensive approach that covers everything from infrastructure and equipment to documentation and staff training. COFEPRIS (the Federal Commission for the Protection against Sanitary Risks) is the authority responsible for overseeing compliance and carrying out inspections.

The key elements covered by Mexican regulation include:

  • Pharmaceutical quality management systems
  • Qualified, trained staff
  • Appropriate facilities and equipment
  • Documentation and records
  • Production and in-process controls
  • Quality control and product release
  • Complaint handling and product recalls
  • Self-inspections and internal audits

Specific GMP Training Requirements Under NOM-059

NOM-059-SSA1-2013 sets specific requirements for training staff in pharmaceutical manufacturing. They are designed to ensure that all staff understand their role within the quality system and have the competencies needed to carry out their responsibilities effectively.

Initial and Ongoing Training

All staff must receive initial training before starting work and ongoing training to keep their competencies current. Initial training should include:

  1. Basic GMP principles and their specific application
  2. Personal hygiene and sanitary practices
  3. Understanding of the pharmaceutical quality system
  4. Applicable standard operating procedures (SOPs)
  5. Occupational health and safety
  6. Handling of pharmaceutical materials and products
  7. Manufacturing documentation and records
  8. Cleaning and sanitization procedures

Competencies by Functional Area

Training should be specific to each person's work area and responsibilities:

Production staff: must be trained in manufacturing procedures, in-process control, deviation handling and prevention of cross-contamination. Training includes technical aspects specific to the production processes and the correct use of manufacturing equipment.

Quality control staff: need specialized training in analytical methods, method validation, interpreting results and making product release decisions. They must understand the acceptance and rejection criteria set out in the specifications.

Warehouse staff: need training in inventory management, storage conditions, the FIFO (first in, first out) system, product segregation and quarantine procedures.

Maintenance staff: must be trained in equipment calibration, preventive maintenance, cleaning process validation and how maintenance activities affect product quality.

Structure and Content of GMP Training Under NOM-059

GMP training to comply with NOM-059 should be systematic and progressive, moving from fundamental concepts to specific applications in the Mexican context. Programs are typically organized into interconnected modules that build competencies gradually.

Module 1: Introduction to GMP and the Mexican Regulatory Framework

This foundational module establishes the conceptual basis of good manufacturing practices and their importance in the Mexican pharmaceutical industry. Participants learn about the evolution of the regulatory framework, the structure of COFEPRIS and the consequences of regulatory non-compliance.

Content includes:

  • The history and evolution of GMP worldwide and in Mexico
  • The structure of the Mexican pharmaceutical regulatory system
  • A detailed analysis of NOM-059-SSA1-2013
  • Its relationship with other applicable Mexican standards
  • The COFEPRIS inspection process
  • Case studies of common non-conformities

Module 2: Pharmaceutical Quality Management System

This module focuses on the principles of the pharmaceutical quality management system under Mexican guidelines. Participants learn how to implement and maintain a robust system that ensures ongoing compliance.

The main topics include:

  • Senior management responsibilities
  • Quality risk management (ICH Q9)
  • Pharmaceutical quality system (ICH Q10)
  • Product quality review
  • Change management
  • Investigation of out-of-specification deviations

Module 3: Personnel and Organization

This training covers the specific requirements for staff in pharmaceutical manufacturing, including qualifications, responsibilities and the importance of a work environment that promotes quality.

Key elements of the module:

  • Organization chart and definition of responsibilities
  • Qualifications of key personnel
  • Training programs and competency assessment
  • Personal hygiene and clothing in production areas
  • Staff health policies
  • Training documentation and personnel records

Putting GMP Training into Practice

Effective GMP training under NOM-059 requires a systematic approach that considers each pharmaceutical organization's specific needs. The implementation approach should be adaptive and consider factors such as company size, process complexity and staff experience.

Training Needs Assessment

Before starting any training program, it is essential to carry out a complete training needs assessment that considers:

  1. Gap analysis between current and required competencies
  2. Assessment of staff's prior knowledge
  3. Identification of the areas of highest regulatory risk
  4. Recent changes to processes or products
  5. Review of previous inspection results
  6. Analysis of trends in deviations and non-conformities

Effective Training Methods

Effective GMP training uses several methods to ensure understanding and retention:

In-person training: interactive sessions that allow discussion of real cases, group problem-solving and immediate clarification of questions. This method is especially effective for complex topics that require discussion and analysis.

On-the-job training: hands-on training in which staff learn by doing the work under the supervision of experienced colleagues. It is crucial for developing practical skills and understanding specific procedures.

Simulations and case studies: real or simulated scenarios used to practice decision-making and applying knowledge. These methods help develop critical thinking and problem-solving skills.

E-learning and digital resources: digital platforms that offer flexible access to training content and track individual progress. They are especially useful for ongoing training and knowledge updates.

Competency Assessment and Certification

Competency assessment is a critical part of any GMP training program. NOM-059 requires organizations to show that their staff have the competencies needed to perform their duties effectively.

Assessment Methods

Assessment methods should fit the type of competency being assessed:

Theoretical assessments: written exams that evaluate understanding of concepts, regulations and procedures. They can include multiple-choice, true/false and open questions that require analysis and synthesis.

Practical assessments: direct observation of how procedures are performed, how equipment is used and how good practices are applied. They are essential to verify that staff can apply what they have learned.

Competency assessments: a comprehensive evaluation that combines theoretical knowledge, practical skills and appropriate attitudes, giving a holistic view of staff competence.

Certification Criteria

Certification criteria should be clear, measurable and aligned with regulatory requirements:

  • A minimum score on theoretical assessments (typically 80% or higher)
  • Successful demonstration of practical skills
  • Understanding of how GMP applies to specific functions
  • The ability to identify and respond to non-conformities
  • Knowledge of documentation and record-keeping procedures

Specialized Training by Pharmaceutical Process

Pharmaceutical manufacturing involves a range of processes that require specialized training. Each process has specific GMP considerations that training must address.

Oral Solid Dosage Manufacturing

Manufacturing oral solid dosage forms requires specific training in:

  • Weighing and dispensing raw materials
  • Blending and granulation
  • Compression and encapsulation
  • Tablet coating
  • Preventing cross-contamination
  • Humidity and temperature control
  • Cleaning process validation

Liquid and Semi-Solid Manufacturing

Manufacturing liquid and semi-solid forms requires special considerations:

  • Preparation and purification of pharmaceutical water
  • Sterilization of equipment and containers
  • Microbiological control
  • Closed transfer systems
  • Sterilization process validation
  • Container-closure system integrity

Sterile Manufacturing

Sterile manufacturing is the most complex area in GMP terms:

  • Cleanroom classification and monitoring
  • Aseptic techniques
  • Sterilization by moist heat, dry heat and filtration
  • Aseptic filling
  • Sterility and endotoxin testing
  • Aseptic process simulation (media fills)
  • Investigation of microbial contamination

Managing Training Documentation

Proper training documentation is a fundamental requirement of NOM-059. Managing it effectively ensures regulatory compliance and makes it easier to demonstrate competencies during inspections.

Required Records

Training records must include detailed, verifiable information:

  1. Identification of the person trained
  2. Dates of initial training and updates
  3. The specific content of the training received
  4. The training method used
  5. The responsible instructor or facilitator
  6. Assessment and certification results
  7. Required recertification dates
  8. Records of ongoing training

Training Management System

A robust training management system should include:

  • A centralized database of training records
  • A competency matrix by job position
  • A recertification calendar
  • Tracking of training effectiveness
  • Integration with the human resources management system
  • Data backup and recovery

Comparing International GMP Requirements

AspectNOM-059 MexicoFDA cGMP (USA)EMA GMP (Europe)ICH Guidelines
Staff TrainingMandatory initial and ongoing trainingAppropriate training requiredRegular, documented trainingCompetency-based training
DocumentationDetailed records requiredComplete, accurate recordsComprehensive documentationRisk-based documentation
AssessmentCompetency assessmentDemonstration of qualificationRegular effectiveness assessmentRisk-based assessment
FrequencyAnnual or as neededPeriodic, based on riskRegular and whenever necessaryBased on risk analysis
ResponsibilityDesignated qualified personQuality managementQualified personQuality management system

Common Implementation Challenges

GMP training programs under NOM-059 face several challenges that organizations must overcome to succeed.

Organizational Challenges

The most common challenges include resistance to change, limited resources and difficulty maintaining training continuity. Resistance to change can appear when staff have prior experience with different systems or see training as an extra burden on top of their regular duties.

Limited resources, both financial and in time, can lead to inadequate or incomplete training programs. Organizations must balance investment in training against other operational priorities, which can result in decisions that compromise the quality or scope of training.

Technical Challenges

Technical challenges include the complexity of some GMP topics, the need for constant updates as regulations change and the difficulty of measuring the real effectiveness of training. Some GMP concepts are inherently complex and require specialized teaching methods to ensure proper understanding.

The pharmaceutical industry is constantly evolving, with new regulations, technologies and best practices emerging regularly. Keeping training current with these developments requires significant resources and a robust knowledge management system.

Best Practices for Effective GMP Training

The success of GMP training under NOM-059 depends on proven best practices that maximize learning effectiveness and ensure sustainable compliance.

Comprehensive Program Design

An effective training program should be designed comprehensively, considering every aspect of pharmaceutical work. The design should include needs analysis, clear learning objectives, appropriate methods and mechanisms for evaluation and continuous improvement.

Training should be relevant to each person's specific responsibilities and connect theory with practical applications in the workplace. Using real examples and case studies from the Mexican pharmaceutical environment significantly increases the relevance and effectiveness of training.

A Focus on Competencies

A competency focus ensures that training centers on the desired outcomes rather than simply covering content. Competencies should be clearly defined, measurable and aligned with regulatory requirements and business needs.

Competency assessment should be continuous and multifaceted, using several methods to give a comprehensive view of staff's ability to perform their duties effectively.

Technology and Innovation in GMP Training

Technology and innovation are transforming how pharmaceutical organizations build their staff's competencies.

Digital Learning Platforms

E-learning platforms offer flexible access to training content, automated progress tracking and learning paths tailored to individual needs. They can include interactive modules, videos, simulations and automated assessments.

Gamification, using game elements such as points, badges and rankings, can increase staff engagement and motivation. It is especially effective for ongoing training and reinforcing concepts.

Virtual Reality and Simulations

Virtual reality is emerging as a powerful training tool for pharmaceutical manufacturing. It makes it possible to create realistic simulations of manufacturing processes, emergencies and critical procedures without the risks of training in a live production environment.

Simulations can be particularly useful for training in sterile manufacturing procedures, handling hazardous materials and responding to critical deviations.

How Leaderlix Approaches GMP Training

Leaderlix Health applies Behavioral Engineering principles to develop GMP training programs that not only meet regulatory requirements but also produce lasting changes in the behavior of pharmaceutical staff. The methodology focuses on identifying and modifying the environmental and systemic factors that influence compliance behavior, going beyond simple knowledge transfer.

Future Trends in Pharmaceutical Training

The future of GMP training is being shaped by technological advances, regulatory change and new insights into effective learning. Emerging trends include more personalized training, the use of artificial intelligence to adapt content and a growing focus on critical thinking and problem-solving skills.

The pharmaceutical industry is also moving toward more integrated approaches that combine GMP training with other management systems such as occupational safety, environmental sustainability and corporate social responsibility.

International Regulation and Harmonization

International harmonization of GMP requirements continues to evolve, with significant implications for training programs. Pharmaceutical organizations operating in several markets must develop training programs that meet local requirements while maintaining global consistency.

Collaboration between regulatory authorities, such as the work of the ICH (International Council for Harmonisation), is bringing requirements closer together, which can simplify training program development for multinational companies.

Conclusions and Recommendations

GMP training under NOM-059 for pharmaceutical manufacturing in Mexico requires a systematic, comprehensive approach adapted to each organization's specific needs. Success depends on committing adequate resources, using effective training methods and keeping a continuous focus on improvement and updating.

Organizations should see GMP training not only as a regulatory requirement but as a strategic investment that contributes to product quality, operational efficiency and business sustainability. Effective training reduces regulatory risk, improves staff morale and supports a quality-centered organizational culture.

To maximize the return on GMP training, organizations should implement robust systems for measuring effectiveness, keep proper documentation and make sure training is integrated with other organizational management systems. Training should be seen as a continuous process rather than an event, with established mechanisms for regular updates and continuous improvement.

Get started

Ready to take the first step?